» Articles » PMID: 36879843

Olfactory Ecto-mesenchymal Stem Cell-derived Exosomes Ameliorate Murine Sjögren's Syndrome Via Suppressing Tfh Cell Response

Overview
Date 2023 Mar 7
PMID 36879843
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the effect of olfactory ecto-mesenchymal stem cell-derived exosomes (OE-MSC-Exos) on T follicular helper (Tfh) cell response and their implication in treating experimental Sjögrens syndrome (ESS).

Methods: C57BL/6 mice were immunized with salivary glands (SG) proteins to induce ESS mouse model. OE-MSC-Exos were added to the Tfh cell polarization condition, and the proportion of Tfh cells was detected by FCM. The PD-L1 of OE-MSCs was silenced with small interfering RNA to extract siPD-L1-OE-MSC-Exos.

Results: We found that transfer of OE-MSC-Exos markedly attenuated disease progression and reduced Tfh cell response in mice with ESS. In culture, OE-MSC-Exos potently inhibited the differentiation of Tfh cells from naïve T cells. Moreover, OE-MSC-Exos expressed high level of the ligand for the programmed cell death protein 1 (PD-L1), knocking down PD-L1 expression in OE-MSC-Exos significantly decreased their capacity to suppress Tfh cell differentiation in vitro. Consistently, transfer of OE-MSC-Exos with PD-L1 knockdown exhibited profoundly diminished therapeutic effect in ESS mice, accompanied with sustained Tfh cell response and high levels of autoantibody production.

Conclusion: Our results suggest that OE-MSC-Exos may exert their therapeutic effect in ameliorating ESS progression via suppressing Tfh cell response in a PD-L1-dependent manner.

Citing Articles

A review of the roles of exosomes in salivary gland diseases with an emphasis on primary Sjögren's syndrome.

Cui X, Liu L, Duan C, Mao S, Wang G, Li H J Dent Sci. 2025; 20(1):1-14.

PMID: 39873057 PMC: 11762945. DOI: 10.1016/j.jds.2024.10.001.


Targeted Therapy for Severe Sjogren's Syndrome: A Focus on Mesenchymal Stem Cells.

Harrell C, Volarevic A, Arsenijevic A, Djonov V, Volarevic V Int J Mol Sci. 2025; 25(24.

PMID: 39769474 PMC: 11677171. DOI: 10.3390/ijms252413712.


Mechanism and application of mesenchymal stem cells and their secreting extracellular vesicles in regulating CD4T cells in immune diseases.

Lin Z, Cai W, Sun Y, Han B, Hu Y, He Z Biophys Rep. 2025; 10(6):403-415.

PMID: 39758422 PMC: 11693500. DOI: 10.52601/bpr.2024.240005.


Emerging Role and Mechanism of Mesenchymal Stem Cells-Derived Extracellular Vesicles in Rheumatic Disease.

Wang Z, Yang C, Yan S, Sun J, Zhang J, Qu Z J Inflamm Res. 2024; 17:6827-6846.

PMID: 39372581 PMC: 11451471. DOI: 10.2147/JIR.S488201.

References
1.
Pflugfelder S, de Paiva C . The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research. Ophthalmology. 2017; 124(11S):S4-S13. PMC: 5657523. DOI: 10.1016/j.ophtha.2017.07.010. View

2.
Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X, Tzioufas A . Topical and systemic medications for the treatment of primary Sjögren's syndrome. Nat Rev Rheumatol. 2012; 8(7):399-411. DOI: 10.1038/nrrheum.2012.53. View

3.
Tian J, Zhu Q, Zhang Y, Bian Q, Hong Y, Shen Z . Olfactory Ecto-Mesenchymal Stem Cell-Derived Exosomes Ameliorate Experimental Colitis Modulating Th1/Th17 and Treg Cell Responses. Front Immunol. 2020; 11:598322. PMC: 7759000. DOI: 10.3389/fimmu.2020.598322. View

4.
Tian J, Rui K, Hong Y, Wang X, Xiao F, Lin X . Increased GITRL Impairs the Function of Myeloid-Derived Suppressor Cells and Exacerbates Primary Sjögren Syndrome. J Immunol. 2019; 202(6):1693-1703. DOI: 10.4049/jimmunol.1801051. View

5.
Tangye S, Ma C, Brink R, Deenick E . The good, the bad and the ugly - TFH cells in human health and disease. Nat Rev Immunol. 2013; 13(6):412-26. DOI: 10.1038/nri3447. View